This compound is primarily used in the field of pharmaceutical research and development, particularly in the synthesis of deuterated drug molecules. Its incorporation of deuterium (d13) enhances the metabolic stability of potential drug candidates, allowing for improved pharmacokinetic profiles and prolonged efficacy. The boronic acid group facilitates its use in Suzuki-Miyaura cross-coupling reactions, a key method for constructing complex organic molecules, including bioactive compounds. Additionally, its piperidine and pyridine moieties make it valuable in the design of molecules targeting neurological and psychiatric disorders, as these structures are often found in drugs interacting with the central nervous system. Its application is also relevant in isotope labeling studies for tracking and analyzing drug metabolism pathways.